INOTUZUMAB OZOGAMICIN

2992 reported adverse events

Drug classes: CD22-directed Immunoconjugate [EPC]

These side effects are most commonly reported by patients taking INOTUZUMAB OZOGAMICIN:

# Side effect Count
0 DEATH 360
1 FEBRILE NEUTROPENIA 267
2 VENOOCCLUSIVE LIVER DISEASE 260
3 OFF LABEL USE 232
4 PYREXIA 198
5 NEOPLASM PROGRESSION 155
6 THROMBOCYTOPENIA 154
7 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 148
8 DRUG INEFFECTIVE 143
9 CYTOKINE RELEASE SYNDROME 142
See all common reactions for INOTUZUMAB OZOGAMICIN

INOTUZUMAB OZOGAMICIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LINEAGE SWITCH LEUKAEMIA 9 0.1698
1 PURTSCHER RETINOPATHY 7 0.0854
2 LEUKAEMIC INFILTRATION EXTRAMEDULLARY 19 0.0745
3 B PRECURSOR TYPE ACUTE LEUKAEMIA 27 0.0696
4 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 148 0.0573
5 VENOOCCLUSIVE DISEASE 132 0.0527
6 VENOOCCLUSIVE LIVER DISEASE 260 0.0526
7 B-CELL TYPE ACUTE LEUKAEMIA 34 0.0463
8 SPONTANEOUS BACTERIAL PERITONITIS 11 0.0451
9 CENTRAL NERVOUS SYSTEM LEUKAEMIA 15 0.0382
See all enriched reactions for INOTUZUMAB OZOGAMICIN